Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Hypertens. 2015 Feb;33(2):412–420. doi: 10.1097/HJH.0000000000000382

Figure 2. Cumulative incidence of Cardiovascular Disease Outcome by Level of Antihypertensive Medication Adherence at Baseline.

Figure 2

Figure 2a: Medication Possession Ratio (MPR)

Figure 2b: Morisky Medication Adherence Scale (MMAS-8)

*P-value for Log-Rank test

CVD-Cardiovascular Disease

MPR—Medication Possession Ratio

MMAS-8—Morisky Medication Adherence Scale 8-item

Composite CVD outcome-myocardial infarction, congestive heart failure, stroke, or cardiovascular death